Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib
Description
The purpose of this study is to see if the combination of Vemurafenib with Decitabine plus Cobimetinib improves the low therapy response rate in subjects with malignant melanoma.